Suchergebnisse - "Singh, Pankaj Kumar"

PubPharm (8)

1

A holistic view on c-Kit in cancer : Structure, signaling, pathophysiology and its inhibitors

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2021

von Pathania, S. | Pentikäinen, O. | Singh, P.

2

Frequent expression of a novel cancer testis antigen, protein kinase human monopolar spindle 1 (hMps1/TTK) in human urinary bladder transitional cell carcinoma

enthalten in: Drug discoveries & therapeutics | 2021

von Singh, P. | Bhatt, M. | Singh, P. | +3

3

Pharmacophore-based designing of putative ROS-1 targeting agents for NSCLC

enthalten in: Molecular diversity | 2021

von Pathak, D. | Choudhary, S. | Singh, P. | +3

4

Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer

enthalten in: Journal of molecular modeling | 2018

von Singh, P. | Silakari, O.

5

Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-MET

enthalten in: Bioorganic chemistry | 2018

von Singh, P. | Silakari, O.

6

Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity

enthalten in: Biochemical and biophysical research communications | 2018

von Shrivastava, R. | Trivedi, S. | Singh, P. | +4

7

Chemotherapeutics-resistance "arms" race : An update on mechanisms involved in resistance limiting EGFR inhibitors in lung cancer

enthalten in: Life sciences | 2017

von Singh, P. | Silakari, O.

8

Novel EGFR (T790M)-cMET dual inhibitors : putative therapeutic agents for non-small-cell lung cancer

enthalten in: Future medicinal chemistry | 2017

von Singh, P. | Silakari, O.

1
[1]